MMDA-3a

Template:Short description Template:Template other{{Infobox drug/maintenance categoriesTemplate:Yesno | drug_name = | INN = | _drugtype =

| _has_physiological_data= | _has_gene_therapy=

| vaccine_type= | mab_type= | _number_of_combo_chemicals= | _vaccine_data= | _mab_data= | _mab_vaccine_data= | _mab_other_data=111513CC(CC1=C(C2=C(C=C1)OCO2)OC)N1S/C11H15NO3/c1-7(12)5-8-3-4-9-11(10(8)13-2)15-6-14-9/h3-4,7H,5-6,12H2,1-2H3OSJXZWMDUMAITM-UHFFFAOYSA-N | _combo_data= | _physiological_data= | _clinical_data= Serotonergic psychedelic; Hallucinogen | _legal_data=

| _other_data=1-(4-methoxy-1,3-benzodioxol-5-yl)propan-2-amine

| _image_0_or_2 = MMDA-3a.svg | _image_LR =

| _datapage = MMDA-3a (data page) | _vaccine_target=_type_not_vaccine | _legal_all= | _ATC_prefix_supplemental= | _has_EMA_link = | CAS_number=23693-19-8 | PubChem=90967 | ChemSpiderID=82148 | ChEBI= | ChEMBL=127603 | DrugBank= | KEGG= | _hasInChI_or_Key=yes | UNII=NY37N4M4KW | _hasJmol02 = |_hasMultipleCASnumbers = |_hasMultiplePubChemCIDs = |_hasMultipleChEBIs =

| _countSecondIDs= | _countIndexlabels= | _trackListSortletter= |QID = |QID2 = |Verifiedfields= |Watchedfields= |verifiedrevid=}}

MMDA-3a, also known as 2-methoxy-3,4-methylenedioxyamphetamine or as 2-methoxy-MDA, is a psychedelic drug of the amphetamine family. It is the 2-methoxy derivative of 3,4-methylenedioxyamphetamine (MDA). The drug produces hallucinogenic effects in humans. Its dosage is listed as 20 to 80mg and its duration as 10 to 16hours in PiHKAL. A higher dose of 100mg was also reportedly explored and doses of 80 to 100mg were said to be very similar to 100μg LSD. MMDA-3a is a positional isomer of MMDA and hence is a Schedule I controlled substance in the United States.

See also

• Substituted methylenedioxyphenethylamine
• Methoxymethylenedioxyamphetamine (MMDA)
• MMDA-1
• MMDA-2
• DMMDA
• DMMDA-2
• MMDA-3b

External links

• MMDA-3a - Isomer Design

Template:Psychedelics